Genomeditech has officially secured global commercial usage rights for HEK293, Jurkat, and CHO-K1 cell lines
Genomeditech now holds global commercial usage rights for HEK293, Jurkat, and CHO-K1 cell lines. These widely used cell lines are essential for research and development in the biopharmaceutical industry. With clear traceability and legal compliance, Genomeditech is helping simplify authorization and accelerate commercialization. Learn more about the advantages and solutions we provide.
2026-06-03